Cancer Research UK logo.
Search
  • Search
Lung cancer cells viewed with a microscope.

Our research into lung cancer

Our research is saving lives

Lung cancer is the third most common cancer in the UK. We played a vital role in reducing the burden of lung cancer through our work to lower smoking rates and protect people from second-hand smoke, but it's still the leading cause of cancer deaths in the UK. Lung cancer survival has lagged behind other cancers, so our scientists are leading the quest for better treatments to bring hope to patients.

Read some examples of ways we've influenced progress in lung cancer

TRACERx research breakthroughs

Lung cancer cells viewed with an electron microscope.

The world's largest cancer evolution study

TRACERx is our flagship multimillion-pound investment in lung cancer research and is revolutionising the way we think about lung cancer. Since 2014, it's uncovered new insights into how tumours evolve over time and in response to treatments. This vital information has changed how we view lung cancer and opened the door to find new ways to treat it more effectively.

Read about how lung cancers evolve

Doctor holding blood sample in test tube.

Catching cancer in the blood

Early TRACERx research revealed that a simple blood test can predict whether a person’s cancer will return after surgery. By detecting traces of tumour DNA in the blood, researchers can tell whether the disease will return up to a year before the tumour is seen on a scan.

Learn more about liquid biopsies

A city skyline obscured by pollution.

Linking lung cancer and air pollution

Most recently, results from TRACERx have shed light on how air pollution could cause cancer in people who have never smoked. Scientists at the Francis Crick Institute and University College London found that exposure to air pollution promotes the growth of cells carrying cancer-causing mutations in the lungs.

Read more about these findings

Manchester Laboratory Image - Brand shoot 2024.

Sharing data to tackle the grand challenges

The TRACERx study has also generated a wealth of data that has been made available to other scientists to use. For example, the Cancer Grand Challenges team CANCAN are tapping into this data to explore cancer cachexia – a wasting syndrome many people with cancer experience characterised by extensive weight loss – in people with lung cancer. 

Find out more about CANCAN

An illustration of a pair of lungs.

TRACERx EVO

In November 2022, Cancer Research UK announced TRACERx EVO. The TRACERx EVO consortium involves international experts from across Europe and North America – combining world-leading scientific and clinical expertise to build on the wide-reaching foundations laid by TRACERx.

Read about the TRACERx EVO programme

A pipette dropping a clear liquid into a test tube.

Current research

From studying the biology of lung cancer cells in the lab to leading clinical trials testing cutting-edge treatments, our researchers are working hard to ensure more people survive lung cancer.

Find out more about our current research

Clear liquid being poured from a Duran bottle into a square container in a lab.

Past research

Thanks to research, we’ve helped change the outlook for people with lung cancer.

Find out more about past research

Explore our timeline of research into lung cancer

A lung cancer patient, Jennifer, standing and smiling in a park.

Patients' stories

Meet people like Jennifer who have experienced first-hand how our research is making a difference. The life-saving research we do wouldn’t be possible without your support.

Read stories from lung cancer patients

Our strategy

Over the last 40 years, cancer survival in the UK has doubled. In the 1970s just 1 in 4 people survived their disease for 10 years or more. Today 2 in 4 survive.

We want to accelerate progress and see 3 in 4 patients surviving the disease by 2034.

Read more about our strategy

Clinical Trials

Cancer News

Browse the latest news, analysis and opinion from Cancer Research UK.

Further information

Want to find more information about our research or lung cancer?

Find out more about clinical trials

More about the symptoms and treatments for lung cancer